Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma

Stromal targeting for pancreatic ductal adenocarcinoma (PDAC) is rapidly becoming an attractive option, due to the lack of efficacy of standard chemotherapy and increased knowledge about PDAC stroma. We postulated that the addition of stromal therapy may enhance the anti‐tumour efficacy of chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: Carapuça, Elisabete F, Gemenetzidis, Emilios, Feig, Christine, Bapiro, Tashinga E, Williams, Michael D, Wilson, Abigail S, Delvecchio, Francesca R, Arumugam, Prabhu, Grose, Richard P, Lemoine, Nicholas R, Richards, Frances M, Kocher, Hemant M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025731/
https://www.ncbi.nlm.nih.gov/pubmed/27061193
http://dx.doi.org/10.1002/path.4727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025731/
https://www.ncbi.nlm.nih.gov/pubmed/27061193
http://dx.doi.org/10.1002/path.4727

Ejemplares similares